{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:03:49Z","timestamp":1784286229085,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.envres.2021.112342","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T17:40:05Z","timestamp":1636134005000},"page":"112342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"PC","title":["Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination"],"prefix":"10.1016","volume":"204","author":[{"given":"Roberta","family":"Pastorino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Maria","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-8731","authenticated-orcid":false,"given":"Leonardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6545-3196","authenticated-orcid":false,"given":"Francesco Andrea","family":"Causio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine","family":"Axfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina G.","family":"Contopoulos-Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-6859","authenticated-orcid":false,"given":"John P.A.","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.envres.2021.112342_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.envres.2021.112342_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2020.7976","article-title":"Estimated SARS-CoV-2 seroprevalence in the US as of september 2020","volume":"181","author":"Bajema","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.envres.2021.112342_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41562-017-0189-z","article-title":"Redefine statistical significance","volume":"2","author":"Benjamin","year":"2018","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.envres.2021.112342_bib4","first-page":"373","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","author":"Bernal","year":"2021","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.envres.2021.112342_bib5","first-page":"262","article-title":"Novel SARS-CoV-2 variants: the pandemics within the pandemic","volume":"S1198\u2013743X","author":"Boehm","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"31","key":"10.1016\/j.envres.2021.112342_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2020.25.31.2001369","article-title":"Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, march and April 2020","volume":"25","author":"Bogogiannidou","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.envres.2021.112342_bib7","series-title":"COVID-19 Vaccination Program Interim Operational Guidance Jurisdiction Operations","year":"2020"},{"key":"10.1016\/j.envres.2021.112342_bib8","first-page":"1","article-title":"Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012\/1: Matched cohort study","volume":"372","author":"Challen","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.envres.2021.112342_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11357-021-00323-3","article-title":"The impact of immuno-aging on SARS-CoV-2 vaccine development","volume":"43","author":"Connors","year":"2021","journal-title":"GeroScience"},{"issue":"6","key":"10.1016\/j.envres.2021.112342_bib10","doi-asserted-by":"crossref","first-page":"102646","DOI":"10.1016\/j.isci.2021.102646","article-title":"SARS-CoV-2 seroprevalence in the urban population of Qatar: an analysis of antibody testing on a sample of 112,941 individuals","volume":"24","author":"Coyle","year":"2021","journal-title":"iScience"},{"issue":"15","key":"10.1016\/j.envres.2021.112342_bib11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.envres.2021.112342_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/diagnostics11040579","article-title":"Mini-Review discussing the reliability and efficiency of COVID-19 vaccines","volume":"11","author":"Doroftei","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.envres.2021.112342_bib14","series-title":"Overview of the Implementation of COVID-19 Vaccination Strategies and Vaccine Deployment Plans in the EU\/EEA","year":"2021"},{"key":"10.1016\/j.envres.2021.112342_bib15","author":"Fornos"},{"issue":"1","key":"10.1016\/j.envres.2021.112342_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-021-02316-5","article-title":"Different aspects of frailty and COVID-19 : points to consider in the current pandemic and future ones","volume":"21","author":"Hussien","year":"2021","journal-title":"BMC Geriatr."},{"issue":"27","key":"10.1016\/j.envres.2021.112342_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2106535118","article-title":"Characterization of a new SARS-CoV-2 variant that emerged in Brazil","volume":"118","author":"Imai","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.envres.2021.112342_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10654-021-00787-9","article-title":"Over- and under-estimaiton of COVID-19 deaths","volume":"36","author":"Ioannidis","year":"2021","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.envres.2021.112342_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjgh-2020-004614","article-title":"Precision shielding for COVID-19: metrics of assessment and feasibility of deployment","volume":"6","author":"Ioannidis","year":"2021","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.envres.2021.112342_bib21","doi-asserted-by":"crossref","first-page":"110856","DOI":"10.1016\/j.envres.2021.110856","article-title":"Second versus first wave of COVID-19 deaths : shifts in age distribution and in nursing home fatalities","volume":"195","author":"Ioannidis","year":"2021","journal-title":"Environ. Res."},{"issue":"579","key":"10.1016\/j.envres.2021.112342_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abd1525","article-title":"Development and deployment of COVID-19 vaccines forthose most vulnerable","volume":"13","author":"Koff","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.envres.2021.112342_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","article-title":"SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse","volume":"6","author":"Konings","year":"2021","journal-title":"Nat. Microb."},{"key":"10.1016\/j.envres.2021.112342_bib24","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1017\/S0950268821000972","article-title":"Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from 3 rounds of community surveys","volume":"149","author":"Kshatri","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.envres.2021.112342_bib25","series-title":"Dnevno Spremljanje Oku\u017eb S SARS-CoV-2 (COVID-19)","year":"2021"},{"key":"10.1016\/j.envres.2021.112342_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijid.2021.03.040","article-title":"Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","volume":"106","author":"Nisar","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"27","key":"10.1016\/j.envres.2021.112342_bib28","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.envres.2021.112342_bib29","unstructured":"PopulationPyramid.net. Population Pyramids of the World from 1950 to 2100 [Internet]. Available from:: https:\/\/www.populationpyramid.net\/."},{"key":"10.1016\/j.envres.2021.112342_bib30","series-title":"SARS-CoV-2 Variants of Concern and Variants under Investigation in England","first-page":"1","year":"2021"},{"issue":"2","key":"10.1016\/j.envres.2021.112342_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyab027","article-title":"Data Resource Profile: COVerAGE-DB: a global demographic database of COVID-19 cases and deaths","volume":"50","author":"Riffe","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.envres.2021.112342_bib32","unstructured":"Serwis Rzeczypospolitej Polskiej - Ministerstwo Zdrowia. Mapy Potrzeb Zdrowotnych -."},{"issue":"7844","key":"10.1016\/j.envres.2021.112342_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2912-6","article-title":"Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City","volume":"590","author":"Stadlbauer","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.envres.2021.112342_bib34","first-page":"1","article-title":"Covid-19: how the Brazil variant took hold of South America","volume":"373","author":"Taylor","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.envres.2021.112342_bib35","series-title":"Tracking the International Spread of SARS-CoV-2 Lineages B. 1.1. 7 and B. 1.351\/501Y-V2","first-page":"6","author":"Toole","year":"2021"},{"issue":"10285","key":"10.1016\/j.envres.2021.112342_bib37","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"},{"issue":"10269","key":"10.1016\/j.envres.2021.112342_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.envres.2021.112342_bib40","author":"Worldometer"}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935121016431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935121016431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:08:11Z","timestamp":1784282891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935121016431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":35,"alternative-id":["S0013935121016431"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2021.112342","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.20.21260842","asserted-by":"object"}]},"ISSN":["0013-9351"],"issn-type":[{"value":"0013-9351","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2021.112342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112342"}}